In studies related to chronic kidney disease (CKD), it has been observed that indole sulfate reduces the vascular protective effects of RAAS inhibitors in CKD patients by inhibiting the NOX/PKC/eNOS pathway [181]. This evidence concerns the gene PRRT2 and chronic kidney disease.